Isoflurane, a halogenated volatile anesthetic, has not been associated
with a distinct hepatic injury syndrome, as has halothane. Previous c
ases of suspected isoflurane-induced hepatotoxicity have been reported
but questioned. We report the case of a patient without previous live
r disease who developed repeated episodes of hepatitis after repeated
exposures to isoflurane. Although no biopsy study was conducted, the t
emporal relationships illustrated in this case strengthen the argument
for isoflurane-induced hepatotoxicity.